Education
About Us
Working with TipRanks
Follow Us
Enzon Pharmaceuticals (ENZN)
OTHER OTC:ENZN
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 26.00K | $ 0.00 | $ 26.00K | $ 701.00K |
| Gross Profit | $ 0.00 | $ 26.00K | $ 0.00 | $ 26.00K | $ 701.00K |
| Operating Income | $ -1.36M | $ -1.33M | $ -1.04M | $ -1.03M | $ -469.00K |
| EBITDA | $ -3.39M | $ 0.00 | $ 3.48M | $ 0.00 | $ 0.00 |
| Net Income | $ -3.41M | $ 778.00K | $ 98.00K | $ -186.00K | $ -469.00K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 42.57M | $ 46.86M | $ 47.01M | $ 46.98M | $ 47.64M |
| Total Assets | $ 42.81M | $ 47.17M | $ 47.70M | $ 47.59M | $ 47.75M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -42.57M | $ -46.86M | $ -47.01M | $ -46.98M | $ -47.64M |
| Total Liabilities | $ 45.34M | $ 44.16M | $ 1.71M | $ 1.70M | $ 403.00K |
| Stockholders' Equity | $ 42.08M | $ 3.01M | $ 45.99M | $ 45.89M | $ 47.35M |
| Cash Flow | |||||
| Free Cash Flow | $ -3.01M | $ 1.12M | $ 1.30M | $ -659.00K | $ -501.00K |
| Operating Cash Flow | $ -3.01M | $ 1.12M | $ 1.30M | $ -659.00K | $ -501.00K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ -1.27M | $ -1.27M | $ -1.27M | $ -1.27M | $ -2.02M |
Enzon Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.